JP2013523181A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523181A5
JP2013523181A5 JP2013505078A JP2013505078A JP2013523181A5 JP 2013523181 A5 JP2013523181 A5 JP 2013523181A5 JP 2013505078 A JP2013505078 A JP 2013505078A JP 2013505078 A JP2013505078 A JP 2013505078A JP 2013523181 A5 JP2013523181 A5 JP 2013523181A5
Authority
JP
Japan
Prior art keywords
sequence
cell
endogenous protein
human
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523181A (ja
JP5841997B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/032218 external-priority patent/WO2011130346A1/en
Publication of JP2013523181A publication Critical patent/JP2013523181A/ja
Publication of JP2013523181A5 publication Critical patent/JP2013523181A5/ja
Application granted granted Critical
Publication of JP5841997B2 publication Critical patent/JP5841997B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505078A 2010-04-13 2011-04-13 内因性にタグ付けされたタンパク質を生成するための方法 Active JP5841997B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US32369810P 2010-04-13 2010-04-13
US32371910P 2010-04-13 2010-04-13
US32370210P 2010-04-13 2010-04-13
US61/323,719 2010-04-13
US61/323,702 2010-04-13
US61/323,698 2010-04-13
US36701710P 2010-07-23 2010-07-23
US61/367,017 2010-07-23
US39066810P 2010-10-07 2010-10-07
US61/390,668 2010-10-07
US40885610P 2010-11-01 2010-11-01
US61/408,856 2010-11-01
US201161431957P 2011-01-12 2011-01-12
US61/431,957 2011-01-12
PCT/US2011/032218 WO2011130346A1 (en) 2010-04-13 2011-04-13 Methods for generating endogenously tagged protein

Publications (3)

Publication Number Publication Date
JP2013523181A JP2013523181A (ja) 2013-06-17
JP2013523181A5 true JP2013523181A5 (https=) 2014-05-08
JP5841997B2 JP5841997B2 (ja) 2016-01-13

Family

ID=44799004

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013505077A Active JP5841996B2 (ja) 2010-04-13 2011-04-13 異種タンパク質を発現するための内因性プロモーターの使用
JP2013505078A Active JP5841997B2 (ja) 2010-04-13 2011-04-13 内因性にタグ付けされたタンパク質を生成するための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013505077A Active JP5841996B2 (ja) 2010-04-13 2011-04-13 異種タンパク質を発現するための内因性プロモーターの使用

Country Status (10)

Country Link
US (5) US20130065310A1 (https=)
EP (2) EP2558574B1 (https=)
JP (2) JP5841996B2 (https=)
KR (2) KR20130054955A (https=)
CN (3) CN102959078B (https=)
BR (1) BR112012026379A2 (https=)
CA (2) CA2795636C (https=)
DK (1) DK2558575T3 (https=)
ES (1) ES2565216T3 (https=)
WO (3) WO2011130343A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512444B2 (en) 2010-07-23 2016-12-06 Sigma-Aldrich Co. Llc Genome editing using targeting endonucleases and single-stranded nucleic acids
US9012617B2 (en) * 2011-04-11 2015-04-21 The Trustees Of The University Of Pennsylvania Detection reagents for tyrosine kinase activity and methods of use thereof
AU2012347919B2 (en) * 2011-12-05 2017-02-02 Factor Bioscience Inc. Methods and products for transfecting cells
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
CA2868575C (en) 2012-03-27 2022-11-01 The University Of Western Ontario Sh2 domain variants
EP2839013B1 (en) * 2012-04-18 2020-08-26 The Board of Trustees of the Leland Stanford Junior University Non-disruptive gene targeting
AU2013335451C1 (en) 2012-10-23 2024-07-04 Toolgen Incorporated Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof
RU2662932C2 (ru) 2013-03-14 2018-07-31 Карибо Биосайенсиз, Инк. Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты
BR112016019940A2 (pt) 2014-03-21 2017-10-24 Univ Leland Stanford Junior edição de genoma sem nucleases
PT3514172T (pt) * 2014-04-01 2020-04-21 Tron Translationale Onkologie An Der Univ Der Johannes Gutenberg Univ Mainz Gemeinnuetzige Gmbh Imunorrecetores específicos de claudina-6 e epítopos de células t
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
EP4464338A3 (en) 2014-11-07 2025-02-12 Editas Medicine, Inc. Systems for improving crispr/cas-mediated genome-editing
US11440946B2 (en) 2015-03-13 2022-09-13 University Of Maryland, Baltimore Universal antibody-mediated biosensor
EP3353296B1 (en) 2015-09-24 2020-11-04 Editas Medicine, Inc. Use of exonucleases to improve crispr/cas-mediated genome editing
KR20250141836A (ko) * 2015-11-04 2025-09-29 페이트 세러퓨틱스, 인코포레이티드 만능 세포의 유전자 조작
WO2017109292A1 (en) * 2015-12-23 2017-06-29 Teknologian Tutkimuskeskus Vtt Oy A method for obtaining indicator signals from a cell
US11597924B2 (en) 2016-03-25 2023-03-07 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
US11236313B2 (en) 2016-04-13 2022-02-01 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
CN106800602B (zh) * 2017-01-22 2020-05-01 中国科学院生物物理研究所 一种可视化标记基因组位点的方法
WO2018148603A1 (en) * 2017-02-09 2018-08-16 Allen Institute Genetically-tagged stem cell lines and methods of use
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
WO2019118879A1 (en) * 2017-12-14 2019-06-20 Donald Danforth Plant Science Center Homologous recombination via transcriptional activation
EP3788150A4 (en) * 2018-05-04 2022-01-26 Sigma-Aldrich Co. LLC PRODUCTION OF RECOMBINANT PROTEINS WITH REDUCED LEVELS OF HOST CELL PROTEINS
WO2020084034A1 (en) 2018-10-26 2020-04-30 F. Hoffmann-La Roche Ag Multispecific antibody screening method using recombinase mediated cassette exchange
EP3902915B1 (en) * 2018-12-30 2023-08-23 F. Hoffmann-La Roche AG Method for the selection of cells based on crispr/cas-controlled integration of a detectable tag to a target protein
EP4031583A4 (en) * 2019-09-16 2023-11-15 Fred Hutchinson Cancer Center CHIMERIC RECEPTOR PROTEINS AND THEIR USES
CN113684228B (zh) * 2021-10-26 2022-03-11 天九再生医学(天津)科技有限公司 利用内参快速准确表征蛋白质相对丰度的方法
CN114703174B (zh) * 2022-04-12 2023-10-24 中国科学院海洋研究所 快速获得基因型和表型突变的CRISPR/Cas9基因敲除方法及应用
CN115948401A (zh) * 2022-12-19 2023-04-11 中国科学技术大学 一种多靶点rna靶向敲低系统及应用
CN120177781B (zh) * 2025-05-22 2025-08-12 南京师范大学 生物传感器及其应用和高通量筛选花姜酮生产菌的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192772B1 (en) * 1988-08-31 2007-03-20 The University Of Florida Research Foundations, Inc. Recombinant cells that highly express chromosomally-integrated heterologous gene
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6495664B1 (en) * 1998-07-24 2002-12-17 Aurora Biosciences Corporation Fluorescent protein sensors of post-translational modifications
US6534261B1 (en) * 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6710170B2 (en) * 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US7125660B2 (en) * 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
AU2002327730A1 (en) * 2001-09-26 2003-04-07 University Of North Carolina At Chapel Hill Variants of alpha-fetoprotein coding and expression sequences
AU2004263865B2 (en) * 2003-08-08 2007-05-17 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US7402436B2 (en) * 2004-05-03 2008-07-22 City Of Hope Lentiviral vectors for site-specific gene insertion
WO2006017751A2 (en) * 2004-08-02 2006-02-16 Cellumen, Inc. Methods for the detection of molecular interactions within cells
AU2005287278B2 (en) * 2004-09-16 2011-08-04 Sangamo Biosciences, Inc. Compositions and methods for protein production
US20060171929A1 (en) * 2005-01-31 2006-08-03 The University Of Washington Regulation of dendritic cell functions by the DCAL-2 receptor
EP1869206A4 (en) * 2005-03-02 2011-08-10 Einstein Coll Med ENZYME SENSORS WITH ENVIRONMENTAL SENSITIVE OR FLUORESCENT LABELS AND APPLICATIONS THEREOF
WO2006094073A2 (en) * 2005-03-02 2006-09-08 Acadia Pharmaceuticals Inc. Functional bioluminescence energy resonance transfer (bret) assay to screen, identify and characterize receptor tyrosine kinase ligands
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
US20070155014A1 (en) * 2005-07-20 2007-07-05 Invitrogen Corporation Methods for increasing efficiency of homologous recombination
US20080305519A1 (en) * 2006-02-23 2008-12-11 Qing Lin Biochemical method for specific protein labeling
WO2007139895A2 (en) * 2006-05-24 2007-12-06 Cellumen, Inc. Method for modeling a disease
EP2205752B1 (en) * 2007-10-25 2016-08-10 Sangamo BioSciences, Inc. Methods and compositions for targeted integration
CA2720903C (en) * 2008-04-14 2019-01-15 Sangamo Biosciences, Inc. Linear donor constructs for targeted integration
SG191561A1 (en) * 2008-08-22 2013-07-31 Sangamo Biosciences Inc Methods and compositions for targeted single-stranded cleavage and targeted integration

Similar Documents

Publication Publication Date Title
JP2013523181A5 (https=)
MY193112A (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
JP2013523180A5 (https=)
SA520411173B1 (ar) Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137
EP4434997A3 (en) Delivery of negatively charged proteins using cationic lipids
AR106752A1 (es) Proteínas de unión a pd1 / ctla4
EP4269577A3 (en) Nucleobase editors and uses thereof
WO2020198509A3 (en) Modified oligonucleotides with increased stability
UA112985C2 (uk) Одноланцюговий поліпептидний гібридний білок
WO2019139645A3 (en) High efficiency base editors comprising gam
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
WO2018073393A3 (en) Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
EP3564259A3 (en) Recognition tags for tgase-mediated conjugation
WO2014202616A3 (en) Rasamsonia gene and use thereof
NZ751946A (en) Rna-guided nucleic acid modifying enzymes and methods of use thereof
FI4269430T3 (fi) Ei-ihmiseläimiä, joilla on humanisoitu signaalin säätelyproteiinigeeni
WO2017011773A3 (en) Codon-optimized nucleic acids encoding antibodies
FI3604532T3 (fi) Uusia crispr-entsyymejä ja järjestelmiä
AU2016277883A8 (en) PD-1-CD28 fusion proteins and their use in medicine
NZ713602A (en) Method for refining protein including self-cutting cassette and use thereof
ZA201703241B (en) Anti-c5 antibodies and methods of use
WO2014172470A3 (en) Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal
WO2009111067A3 (en) Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation
EA201591131A1 (ru) Днк-конструкции антитела и способ их применения
WO2016063026A3 (en) Selective nav protein binders